KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) EBT: 2015-2025

Historic EBT for Medpace Holdings (MEDP) over the last 10 years, with Sep 2025 value amounting to $142.8 million.

  • Medpace Holdings' EBT rose 20.26% to $142.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $519.4 million, marking a year-over-year increase of 20.03%. This contributed to the annual value of $475.9 million for FY2024, which is 41.78% up from last year.
  • Latest data reveals that Medpace Holdings reported EBT of $142.8 million as of Q3 2025, which was up 14.69% from $124.5 million recorded in Q2 2025.
  • Over the past 5 years, Medpace Holdings' EBT peaked at $142.8 million during Q3 2025, and registered a low of $42.7 million during Q2 2021.
  • Moreover, its 3-year median value for EBT was $112.8 million (2024), whereas its average is $108.8 million.
  • Data for Medpace Holdings' EBT shows a peak YoY surged of 49.61% (in 2022) over the last 5 years.
  • Quarterly analysis of 5 years shows Medpace Holdings' EBT stood at $55.9 million in 2021, then soared by 31.69% to $73.6 million in 2022, then rose by 23.17% to $90.7 million in 2023, then spiked by 47.60% to $133.9 million in 2024, then grew by 20.26% to $142.8 million in 2025.
  • Its last three reported values are $142.8 million in Q3 2025, $124.5 million for Q2 2025, and $118.2 million during Q1 2025.